Utilizing a cell phone based microscope for recognizing single molecules and diagnosing infections Kumar Jeetendra | February 14, 2021 Biomarkers play a central role in the identification of disease and evaluation of its course. Among the markers now in use are genes, hormones, proteins, lipids and other types of molecules. Biomarkers can be found in the bloodstream, in cerebrospinal fluid, urine and various types of tissues, but many of them have one thing in …
INTEGRA’s electronic pipettes empower reproducible examination in microbial analysis Kumar Jeetendra | March 17, 2021 Bacterial evolution studies involve analysis of large sample numbers, requiring compact, reproducible pipetting processes to effectively characterize the qualities of different strains. Dr Astrid Altamirano-Junqueira, who completed her doctoral studies into the growth of bacterial motility in the School of Biological Studies at Reading University, discussed how these digital pipettes aided her research:”My focus was …
Secret genetic defects can prompt a wide range of serious illnesses Kumar Jeetendra | March 20, 2021 For the first time researchers from Hebrew University of Jerusalem, Radboudumc, Maastricht UMC+ and worldwide colleagues have gained insight to the”hidden genetic defects” of the general European population. This is important as these defects, if inherited from the father and mother, can result in all kinds of disorders in their children. Research in the Dutch …
New stage helps non-specialists use AI to examine microscopy pictures Kumar Jeetendra | April 24, 2021 A new, publicly available platform helps non-experts utilize artificial intelligence to examine microscopy images. The platform has been developed at Åbo Akademi University in Finland and Instituto Gulbenkian de Ciência, Portugal, and will be of big help in research and diagnostics using modern day microscopes. Software using artificial intelligence, AI, is revolutionizing how microscopy images …
Novel platform has potential to detect many disease-related biomarkers in just one test Kumar Jeetendra | April 28, 2021 Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or …
Novel technique gives quicker and more exact diagnostics in histopathology Kumar Jeetendra | May 1, 2021 Histology is the study of biological cells at a microscopic level. Also called microscopic anatomy, histology is widely used to offer identification of cancer and other diseases. For instance, tissue samples obtained during surgery might help to ascertain whether additional surgical action is needed, and additional surgery may be avoided if a diagnosis can be …
New COVID-19 testing innovation is a less expensive, quicker choice to tube-based RT-PCR tests Kumar Jeetendra | May 18, 2021 Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have restricted the rapid expansion of clinical testing required to contain the virus. Its accuracy was 100 percent predictive in clinical trials, researchers explain in The Journal of Molecular Diagnostics, published by Elsevier. Sensitivity is critical for early detection of COVID-19 infection where …
New testing protocols for SARS-CoV-2 can handle a huge number of tests inside 48 hours Kumar Jeetendra | May 25, 2021 Researchers in the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is printed in the journal Nature Communications and might be adapted to many more pathogens. The COVID-19 pandemic has lasted more than a year and continues to …
MRI screening and designated biopsies could diminish overdiagnoses of prostate malignant growth Kumar Jeetendra | July 10, 2021 Many countries do not have nationwide prostate-cancer screening. Current methods lead to overdiagnoses, unnecessary biopsies, and unnecessary biopsies. Researchers at Karolinska Institutet, Sweden, have published a new study in The New England Journal of Medicine. It shows that targeted biopsies and magnetic resonance imaging (MRI), could reduce overdiagnoses by up to half. These results were …
New technique to make a modest and rapid COVID-19 test dependent on isothermal amplification Kumar Jeetendra | December 30, 2021 Russian researchers have devised the method to make an affordable and quick COVID-19 test that relies on isothermal amplifying. According to their paper in Applied Biochemistry and Microbiology The using this method can allow researchers to create universal test methods for any COVID-19 variations. There are many options for devices that detect the presence of SARS-CoV-2 within human …
ADMI Announces New Leadership Team Kumar Jeetendra | May 27, 2022 Association of Diagnostics Manufacturers of India (ADMI) has announced a new leadership team for the period 2022-2025. The new leadership team comprises 1.Mr Thomas John – President (also MD, Agappe Diagnostics) 2.Mr Veeraal Gandhi – Vice President ( also Founder Chairman, Voxtur Bio Ltd) 3.Mr Jatin Mahajan – Secretary (also Managing Director, J Mitra & …
Nanomedicine for liver cancer developed by Amrita researchers gets US, Australia patent Kumar Jeetendra | September 13, 2022 Mumbai 13th Sept, 2022: Researchers from the School of Nanosciences & Molecular Medicine at Amrita Vishwa Vidyapeetham have won a patent in the US and Australia for a novel nanomedicine that holds great promise for early detection and treatment of liver cirrhosis and liver tumor. The invention is the outcome of a research project funded …
